Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF 21.30
+0.30 (1.43%)
Last updated: May 13, 2025
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 120.58 million as of May 13, 2025. Its market cap has decreased by -36.51% in one year.
Market Cap
120.58M
Enterprise Value
271.06M
Revenue
834.88K
Ranking
n/a
PE Ratio
4.63
Stock Price
21.30
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 120.58M, a decrease of -49.86%. That is a compound annual growth rate of -19.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 117.71M | -19.29% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 209.97B |
| Novartis AG | 178.12B |
| Lonza Group AG | 40.67B |
| Alcon | 39.60B |
| Galderma Group AG | 23.81B |
| Straumann Holding AG | 17.82B |
| Sandoz Group AG | 16.28B |
| Sonova Holding AG | 15.87B |